You are here:
Home
NICE Guidance
Conditions and diseases
Digestive tract conditions
Inflammatory bowel disease
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]
Topic selection
Project information
Project documents
30946-Ustekinumab-for-Crohns-Disease-V1.0-NOV2023-NON-CONF.pdf (nihr.ac.uk)
Back to top